DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Myelin Repair Foundation
Myelin Repair Foundation
Development of a Central Nervous System Axonal Myelination Assay for High Throughput Screening Karen D
October 2004
MRF Archive Compiled Research Summaries
Cerebellar Syndrome in a Man Treated with Natalizumab from the National Multiple Sclerosis Society Case Conference Proceedings
Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation
Neurimminfl2015006502 1..11
Senior Investigator and Chief, Translational Neuroradiology Section Division of Neuroimmunology and Neurovirology National Insti
Demyelinating Disease Models of Central Nervous System
BIOGRAPHICAL SKETCH Provide the Following Information for the Key Personnel and Other Significant Contributors in the Order Listed on Form Page 2
Background and Significance
Demyelination Disorders MS ALS Multiple Sclerosis
Making Myelin
Evaluating the Safety of B-Interferons in MS a Series of Nested Case-Control Studies
Development of a High Throughput Drug Screening Assay to Identify
Dr Peter Calabresi, Curriculum Vitae
Poster Session 1
Multiple Sclerosis
Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis
Top View
A High Throughput Drug Screening Assay to Identify Compounds That
2012 AACR CPR Text 2.0 Layout 1 10/20/12 4:27 AM Page 1
Multiple Sclerosis:The Basics
Multiple Sclerosis & Immune Disorders
From the National Multiple Sclerosis Society Case Conference Proceedings
Repair Foundation: Two Routes to New MS Drugs
Rare Diseases and Orphan Products: Accelerating Research and Development
Fully for Preclinical Evaluation of a Candidate MS Treatment
Jack Antel Department of Neurology and Neurosurgery Montreal Neurological Institute Montreal, Québec, Canada
Effect of the Sphingosine-1-Phosphate Receptor Modulator Ozanimod on Leukocyte Subtypes in Relapsing MS Sarah Harris, Jonathan Q
2016 Medicines in Development for Autoimmune Diseases
(12) United States Patent (10) Patent No.: US 8,415,106 B2 Popko Et Al
Neurimminfl2015007716 1..7